Tag: covid
-
That was quick! Xphyto (XPHY.C) orders 9,600 Covid-19 PCR tests – stock up 67% year-to-date
“PCR tests are used to directly detect the presence of an antigen, rather than the presence of the body’s immune response, or antibodies,” states Medical Device Network, “By detecting viral RNA, which will be present in the body before symptoms of the disease are present,” the tests give a powerful early warning system.
-
![Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test]()
Xphyto (XPHY.C) assembles biotech/biz dream-team to launch 25-minute Covid-19 test
The PCR test system demonstrated clinical accuracy in detecting SARS-CoV-2 RNA within 25 minutes, making it an ideal screening tool for international airports.
-
![Manganese X (MN.V) drill program intersects wide zones of manganese oxide near surface up to 27.69%]()
Manganese X (MN.V) drill program intersects wide zones of manganese oxide near surface up to 27.69%
The Battery Hill drill program of 28 holes totalling 4509 meters was designed to increase the mineral resource in the Moody Hill area and to provide sufficient data to establish a NI 43-101 compliant mineral resource estimate expected in late Q1 2021.
-
![Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine]()
Xphyto’s (XPHY.C) lays out its ambitious Parkinson’s/Epilepsy/Depression/Multiple Sclerosis drug formulation strategy which includes heavy investment in psychedelic medicine
Xphyto describes itself as “a bioscience accelerator” “targeting growth through commercialization of its product pipeline”.
-
![Manganese X (MN.V) stock surges 75% on good metallurgy and Joe Biden’s green energy plan.]()
Manganese X (MN.V) stock surges 75% on good metallurgy and Joe Biden’s green energy plan.
“The news keeps getting better in the processing of the Battery Hill manganese ore,” stated Manganese X CEO Martin Kepman, “Recovery rates are impressive, and the applied process for purification has been refined to achieve greater efficiency and improved economics.”
-
Immunoprecise Antibodies (IPA.V), or should I say (NASDAQ: IPA)
Before we start, let’s give a big round of applause to Immunoprecise Antibodies Ltd and all its staff and its management. They are headed to the big leagues, ladies and gentlemen – a straight path towards listing on the Nasdaq (begin trading on Nasdaq on December 30th, 2020). I’m not a parent myself (unless you…
-
![Manganese X (MN.V) spins out Quebec graphite property]()
Manganese X (MN.V) spins out Quebec graphite property
On December 23, 2020 Manganese X (MN.V) announced that it’s 100%-owned subsidiary, Graphano will spin-out the Lac Aux Bouleaux (LAB) graphite property, located in the province of Quebec, Canada.
-
Revive Therapeutics (RVV.C) shareholders experience intense vertigo
Investor focus is currently bifurcated between a potential FDA bucillamine approval, and RVV’s ambitions and partnerships in the shroom space.
-
Can scrappy Valeo Pharma (VPH.C) win a Stanley Cup?
“With more than 8 years of proven in-market safety internationally and a robust supply chain ensuring product availability, we expect Redesca to play a major role in the achievement of our growth objectives,” stated Saviuk.
